Pages that link to "Q36760261"
Jump to navigation
Jump to search
The following pages link to Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease (Q36760261):
Displaying 50 items.
- Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria (Q21245230) (← links)
- Using animal models to determine the significance of complement activation in Alzheimer's disease (Q24796236) (← links)
- Common mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation (Q26766681) (← links)
- Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers (Q26825442) (← links)
- The genetics and neuropathology of Alzheimer's disease (Q26998097) (← links)
- The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer's disease phenotype (Q26999358) (← links)
- Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities (Q28086879) (← links)
- The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease (Q28139932) (← links)
- Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization (Q28191605) (← links)
- Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells (Q28566143) (← links)
- Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction (Q28576073) (← links)
- R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer's disease (Q30684317) (← links)
- NADPH oxidase as a therapeutic target in Alzheimer's disease (Q30855129) (← links)
- Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia (Q31033082) (← links)
- beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. (Q31840031) (← links)
- The use of analgesics in the management of pain in rheumatic diseases (Q33542921) (← links)
- Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli (Q33678241) (← links)
- Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease (Q33732327) (← links)
- Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease (Q33803741) (← links)
- Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-κB activation in cultured astrocytes and microglial BV-2 cells (Q33877126) (← links)
- Does the insulin-like growth factor system interact with prostaglandins and proinflammatory cytokines during neurodegeneration? (Q33899264) (← links)
- Genetic dissection of Alzheimer disease, a heterogeneous disorder (Q33909158) (← links)
- Will antioxidants fulfill their expectations for the treatment of Alzheimer disease? (Q34038304) (← links)
- Treatment of Alzheimer's disease: rationale and strategies (Q34079586) (← links)
- Part VI. Primary drug therapies for Alzheimer's disease (Q34113964) (← links)
- Animal models of Alzheimer's disease and evaluation of anti-dementia drugs (Q34126136) (← links)
- Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain (Q34274025) (← links)
- Alzheimer's disease: a review for the ophthalmologist (Q34293009) (← links)
- Genome-wide association studies in Alzheimer's disease: a review (Q34364850) (← links)
- Control of the complement system. (Q34400002) (← links)
- Antioxidants as treatment for neurodegenerative disorders (Q34974866) (← links)
- Cannabinoids and neuroinflammation (Q35046205) (← links)
- The impact of systemic infection on the progression of neurodegenerative disease. (Q35058498) (← links)
- The evolving biology of microglia in Alzheimer's disease. (Q35064995) (← links)
- Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration (Q35150586) (← links)
- Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria (Q35170207) (← links)
- Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells (Q35521795) (← links)
- Update on epidemiological aspects of progressive supranuclear palsy (Q35540189) (← links)
- Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment. (Q35666080) (← links)
- Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (Q35881235) (← links)
- Frontal Cortex Neuropathology in Dementia Pugilistica (Q35886739) (← links)
- Microglia in Alzheimer's Disease: It's All About Context (Q36072124) (← links)
- TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance (Q36073450) (← links)
- Prevention of Dementia (Q36253368) (← links)
- Cannabinoid CB2 receptors in human brain inflammation (Q36416377) (← links)
- Alzheimer's disease, brain immune privilege and memory: a hypothesis (Q36577655) (← links)
- Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation (Q36607332) (← links)
- A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease (Q36862366) (← links)
- Activated Microglial Cells Are Colocalized With Perivascular Deposits of Amyloid-β Protein in Alzheimer’s Disease Brain (Q36887427) (← links)
- Alzheimer's disease and mild cognitive impairment (Q36894385) (← links)